1. Home
  2. PMCB vs MTR Comparison

PMCB vs MTR Comparison

Compare PMCB & MTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMCB
  • MTR
  • Stock Information
  • Founded
  • PMCB 1996
  • MTR 1979
  • Country
  • PMCB United States
  • MTR United States
  • Employees
  • PMCB N/A
  • MTR N/A
  • Industry
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • MTR Oil & Gas Production
  • Sector
  • PMCB Health Care
  • MTR Energy
  • Exchange
  • PMCB Nasdaq
  • MTR Nasdaq
  • Market Cap
  • PMCB 11.4M
  • MTR 12.6M
  • IPO Year
  • PMCB N/A
  • MTR N/A
  • Fundamental
  • Price
  • PMCB $1.76
  • MTR $6.39
  • Analyst Decision
  • PMCB
  • MTR
  • Analyst Count
  • PMCB 0
  • MTR 0
  • Target Price
  • PMCB N/A
  • MTR N/A
  • AVG Volume (30 Days)
  • PMCB 27.2K
  • MTR 5.6K
  • Earning Date
  • PMCB 03-17-2025
  • MTR 01-01-0001
  • Dividend Yield
  • PMCB N/A
  • MTR 2.81%
  • EPS Growth
  • PMCB N/A
  • MTR N/A
  • EPS
  • PMCB 0.74
  • MTR 0.35
  • Revenue
  • PMCB N/A
  • MTR $966,169.00
  • Revenue This Year
  • PMCB N/A
  • MTR N/A
  • Revenue Next Year
  • PMCB N/A
  • MTR N/A
  • P/E Ratio
  • PMCB $2.37
  • MTR $18.29
  • Revenue Growth
  • PMCB N/A
  • MTR N/A
  • 52 Week Low
  • PMCB $1.39
  • MTR $5.60
  • 52 Week High
  • PMCB $2.58
  • MTR $11.99
  • Technical
  • Relative Strength Index (RSI)
  • PMCB 60.08
  • MTR 48.62
  • Support Level
  • PMCB $1.57
  • MTR $6.02
  • Resistance Level
  • PMCB $1.66
  • MTR $6.25
  • Average True Range (ATR)
  • PMCB 0.12
  • MTR 0.23
  • MACD
  • PMCB 0.02
  • MTR -0.03
  • Stochastic Oscillator
  • PMCB 68.89
  • MTR 39.78

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

About MTR Mesa Royalty Trust

Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.

Share on Social Networks: